Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Immunology/Inflammation related
    (6)
  • BTK
    (3)
  • TNF
    (2)
  • ADC Antibody
    (1)
  • Acetyl-CoA Carboxylase
    (1)
  • Apoptosis
    (1)
  • CD38
    (1)
  • CD73
    (1)
  • EGFR
    (1)
  • Others
    (21)
TargetMol | Tags By Application
  • ELISA
    (7)
  • Functional assay
    (7)
  • FCM
    (5)
  • FACS
    (2)
TargetMol | Tags By ResearchField
  • Cancer
    (7)
  • Inflammation
    (6)
  • Immune System
    (4)
  • Metabolism
    (2)
  • Infection
    (1)
  • Nervous System
    (1)
Filter
Search Result
Results for "

fcγr

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    14
    TargetMol | All_Pathways
  • Peptide Products
    1
    TargetMol | Peptide_Products
  • Inhibitory Antibodies
    20
    TargetMol | Inhibitory_Antibodies
  • Reagent Kits
    2
    TargetMol | Reagent_Kits
  • Recombinant Protein
    77
    TargetMol | Recombinant_Protein
  • Antibody Products
    76
    TargetMol | Antibody_Products
  • Research Areas
    3
    TargetMol | Research_Areas
  • ADC/ADC Related
    1
    TargetMol | All_Pathways
BIIB068
T91921798787-27-5
BIIB068 is an selective, reversible and orally active BTK inhibitor (IC50 = 1 nM, Kd = 0.3 nM). BIIB068 is 400 times more selective for BTK than other kinases.
  • $40
In Stock
Size
QTY
TargetMol | Citations Cited
Rozanolixizumab
UCB7665
T390571584645-37-3
Rozanolixizumab (RYSTIGGO) is a high-affinity humanized immunoglobulin G4 monoclonal antibody targeting Fc receptors (FcRn) in human newborns for the study of pathogenic IgG in autoimmune and alloimmune diseases.
  • $228
In Stock
Size
QTY
Alemtuzumab
T9919216503-57-0
Alemtuzumab is a humanized monoclonal antibody against CD52 an antigen found on the surface of normal and malignant lymphocytes.
  • $297
In Stock
Size
QTY
Obinutuzumab
GA101
T9924949142-50-1
Obinutuzumab (Obinutuzumab/afutuzumab) GA101) is a glycoengineered Type II CD20 monoclonal antibody in development for non-Hodgkin lymphoma.
  • $247
In Stock
Size
QTY
Ofatumumab
T9925679818-59-8
Ofatumumab is a humanized monoclonal antibody targeting CD20. Ofatumumab acts on CD20-expressing B lymphocytes, inducing antibody-dependent cell-mediated cytotoxicity and complement-dependent cytotoxicity.
  • $239
In Stock
Size
QTY
Haloxyfop
Haloxyfop Acid, (±)-Haloxyfop
T504669806-34-4
(±)-Haloxyfop (Haloxyfop Acid) is a herbicide.
  • $40
In Stock
Size
QTY
hIgG–hFc receptor-IN-1
T637151425051-22-4
hIgG-hFc receptor-IN-1 is a human immunoglobulin G - human neonatal Fc receptor (hIgG-hFcRn) protein-protein interaction inhibitor (IC50: 2 μM).
  • $1,520
6-8 weeks
Size
QTY
F-CRI1
T79199
F-CRI1, a potent STING agonist with a dissociation constant (K d) of 40.62 nM, is an 18F-labeled radioactive probe employed for visualizing STING in the tumor microenvironment [1].
  • Inquiry Price
Inquiry
Size
QTY
Anti-Rat FcRn heavy chain heterodimers Antibody (2G3)
2G3
T9901A-1213
Anti-Rat FcRn heavy chain heterodimers Antibody (2G3) is an IgG1 antibody inhibitor derived from mice, specifically targeting rat FcRn heavy chain heterodimers.
    Inquiry
    Rilzabrutinib
    PRN1008
    T125421575596-29-0
    Rilzabrutinib (PRN1008) is a reversible covalent, selective, and orally active inhibitor of Bruton's Tyrosine Kinase (BTK) with an IC50 of 1.3 nM.
    • $100
    In Stock
    Size
    QTY
    BTK-IN-11
    T632542765852-46-6
    BTK-IN-11 is a potent BTK inhibitor with potential applications in research on autoimmune diseases, inflammatory diseases, and cancer.
    • $2,140
    8-10 weeks
    Size
    QTY
    Mupadolimab
    CPI-006
    T767352451856-97-4
    Mupadolimab (CPI-006) is a humanized FC-γR binding deficient IgG1 anti-CD73 antibody with potential anticancer activity and activation of CD73POS B cells.
    • $222
    In Stock
    Size
    QTY
    PKC-ε translocation inhibitor peptide
    T81449
    PKC-ε Translocation Inhibitor Peptide is a selective modulator that controls the FcγR-mediated internalization rate of opsonized beads without affecting FcαR trafficking [1].
    • Inquiry Price
    Inquiry
    Size
    QTY
    BI-1808
    T9901A-944
    BI-1808 is a human IgG1 monoclonal antibody targeting TNFR2. It blocks the interaction between TNFR2 and its ligand TNF-α, leading to FcγR-dependent regulatory T cell depletion and facilitating the expansion of intratumoral CD8+ T cells.
    • Inquiry Price
    Inquiry
    Size
    QTY